In UK Allen & Overy, advised on the matter. Allen & Overy advised Exscientia with a team including Jim Ford (Picture – Life Science & Health...
This content is for members only.
Join Now
Join Now
Already a member? Log in here
Exscientia’s $674m AI Drug Discovery Collaboration with Merck KGaA
Exscientia’s USD5.2 Billion Strategic Research Collaboration with Sanofi
In UK Allen & Overy, advised on the matter. Allen & Overy advised Exscientia with a team including Jim Ford (Picture – Life Science & Health...
This content is for members only.
Join Now
Join Now
Already a member? Log in here
Exscientia’s $510.4 Million IPO
In UK Cooley LLP, Goodwin Procter, advised on the matter. Cooley LLP advised Exscientia with a team including David Boles (Picture – Equity Capital Markets), Claire...
This content is for members only.
Join Now
Join Now
Already a member? Log in here
Exscientia’s Oncology Joint Venture With GT Apeiron Therapeutics
In UK Allen & Overy, advised on the matter. Allen & Overy advised Exscientia with a team including Jim Ford (Picture – Corporate M&A), Life Science...
This content is for members only.
Join Now
Join Now
Already a member? Log in here
Exscientia’s USD 1.2 Billion Collaboration With Bristol Myers Squibb
In UK Allen & Overy, advised on the matter. Allen & Overy advised Exscientia with a team including Jim Ford (Picture – Life Science & Healt...
This content is for members only.
Join Now
Join Now
Already a member? Log in here
Exscientia’s $225 Million Series D Funding Round
In UK Cooley LLP, advised on the matter. Cooley LLP advised Exscientia with a team including Paula Holland (Human Capital), Claire Keast-Butler (Picture – Corporate M&A)....
This content is for members only.
Join Now
Join Now
Already a member? Log in here